ENDOXAN

This brand name is authorized in Australia, Austria, Croatia, Cyprus, Ecuador, Estonia, France, Germany, Hong Kong SAR China, Israel, Japan, Lithuania, Malta, Netherlands, New Zealand, Poland, Romania, Singapore, South Africa, Tunisia, Turkey.

Active ingredients

The drug ENDOXAN contains one active pharmaceutical ingredient (API):

1	Cyclophosphamide monohydrate UNII 6UXW23996M - CYCLOPHOSPHAMIDE ANHYDROUS
	Cyclophosphamide has been demonstrated to have a cytostatic effect in many tumour types. The active metabolites of cyclophosphamide are alkylating agents which transfer alkyl groups to DNA during the process of cell division, thus preventing normal synthesis of DNA.
	Read more about Cyclophosphamide

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC Group		Classification
L01AA01	Cyclophosphamide	L Antineoplastic and immunomodulating agents → L01 Antineoplastic agents → L01A Alkylating agents → L01AA Nitrogen mustard analogues
Discover more medicines within L01AA01

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
AU	Pharmaceutical Benefits Scheme	4327R, 7226H
DE	Bundesinstitut für Arzneimittel und Medizinprodukte	00334534, 03141876, 04959337, 04959343, 11350192
EC	Agencia Nacional de Regulación, Control y Vigilancia Sanitaria	12.869-4-07-06, 12.870-4-07-06
EE	Ravimiamet	1021790, 1021802, 1021813, 1021824, 1124121
FR	Base de données publique des médicaments	62554177, 64635418, 69586327
HK	Department of Health Drug Office	01327, 51308, 51711
HR	Agencija za lijekove i medicinske proizvode	HR-H-082504880, HR-H-141815990, HR-H-857890693, HR-H-921138904
IL	מִשְׂרַד הַבְּרִיאוּת	4080, 4081
JP	医薬品医療機器総合機構	4211002F1044, 4211002X1023, 4211401D1033, 4211401D2021
LT	Valstybinė vaistų kontrolės tarnyba	1000705, 1000707, 1000708, 1004882, 1071140, 1079722, 1079980, 1079981, 1079982, 1080562, 1083567
MT	Medicines Authority	PI565/76701A
NL	Z-Index G-Standaard, PRK	105333, 125164, 957
NZ	Medicines and Medical Devices Safety Authority	2694, 2695
PL	Rejestru Produktów Leczniczych	100022145, 100022151, 100022174, 100400618
RO	Agenția Națională a Medicamentului și a Dispozitivelor Medicale	W12490001, W12491001, W12492001, W12493001, W64372001
SG	Health Sciences Authority	00929P, 00930P, 01747P, 01748P
TN	Direction de la Pharmacie et du Médicament	2163031H, 2163032H, 2163133H
TR	İlaç ve Tıbbi Cihaz Kurumu	8681413881039, 8681413881046, 8681413881053, 8681413881060
ZA	Health Products Regulatory Authority	A38/26/0593